A new era in moderate- to- severe Atopic Dermatitis : Using Abrocitinb to get patients on the Right track
In this webinar, a detailed discussion is done on a new era in moderate- to- severe Atopic Dermatitis : Using Abrocitinb to get patients on the Right
Speakers : Dr. Sandipan Dhar ,Dr. Shireen Furtado ,Dr. Ramesh Bhat ,Dr. Debjit Kar ,Dr. Maitreyee Panda
New advances in the management of Atopic dermatitis & role of PDE4 Inhibitor
In this webinar, a detailed discussion is done through the interesting session on the new advances in the management of atopic dermatitis.
Speakers : Dr. Anup Kumar Lahiry ,Dr. Rajetha Damisetty ,Dr. Raghavendra Rao ,Dr. V Anand Kumar ,Dr. C Brijesh Nair
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Congresswoman has cancer; the IRS is suing a controversial doctor; and caffeine and teenagers.
2.
In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.
3.
Nuclear missile workers are contracting cancer: They blame the bases
4.
The FDA approves alexinib as an adjuvant treatment for non-small cell lung cancer.
5.
Train Eyes so Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke
1.
Unlocking the Immune Arsenal: A Revolution in Cancer Treatment
2.
Mechanistic Insights into Abraxane, Verzenio, and the Management of Chemotherapy-Induced Tachycardia
3.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
4.
Interplay of Brown Hair, Follicular Biology, and Hair Growth Inhibitors in Melanoma Pathogenesis
5.
PARP Inhibitors in Testicular Cancer: Tackling Cisplatin Resistance with Precision
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
2.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge